CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment - Concepedia

Concepedia

Publication | Open Access

CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment

DOI Full Paper Access

40

Citations

92

References

2021

Year

Jennifer E. Klomp, Ye S. Lee, Craig M. Goodwin, Bjoern Papke, Jeffrey A. Klomp, Andrew M. Waters, Clint A. Stalnecker, Jonathan M. DeLiberty, Kristina Drizyte‐Miller, Runying Yang,

Cancer ResearchOncogenic Kras-expressing CellsDna DamagePancreatic CancerCell RegulationOncogenic AgentMedicineCell DeathTumor SuppressorPancreatic Cancer TreatmentRadiation OncologyCancer BiologyCell BiologyCell SignalingTumor Biology

References

	Year	Citations

Page 1

Page 1